8-K: Waters Corp Reports Strong Q2 2026, Raises Full-Year Guidance

Waters Corporation announced robust second quarter 2026 financial results, exceeding guidance with strong revenue growth and raising its full-year financial outlook.

Summary

• Waters Corporation reported second quarter 2026 total revenue of $1.645 billion, surpassing guidance.
• Organic revenue grew 7% as reported and 9% in constant currency, with the Analytical Sciences Division (ASD) showing 8% instrument growth and double-digit consumables growth.
• Biosciences and Diagnostic Solutions (BDS) revenue was $817 million, exceeding guidance by $15 million and growing 4% year-over-year.
• Adjusted EPS for the quarter was $3.05, at the high end of guidance, with GAAP EPS at ($1.39) due to acquisition-related charges.
• The company is raising its full-year 2026 guidance, now expecting 7% to 9% organic constant currency revenue growth and adjusted EPS of $14.45 to $14.65 (10-12% growth).

Sentiment

Score: 8

Explanation: StockSavvy.ai views this as a positive report, with strong revenue growth, raised full-year guidance, and successful integration of acquired businesses, indicating robust operational performance and a favorable outlook.

Positives

• Total reported revenue of $1.645 billion exceeded the high end of guidance.
• Organic revenue grew 9% in constant currency, driven by broad-based outperformance.
• Analytical Sciences Division (ASD) achieved 8% instrument growth and double-digit chemistry consumables growth.
• Biosciences and Diagnostic Solutions (BDS) revenue grew 4% year-over-year and exceeded guidance by $15 million.
• Adjusted EPS of $3.05 met the high end of guidance.
• Full-year 2026 guidance has been raised across all components.
• The company expects full-year 2026 organic constant currency revenue growth of 7% to 9%.
• Full-year 2026 adjusted EPS guidance is raised to $14.45 $14.65, representing 10-12% growth.

Negatives

• Reported a GAAP diluted loss per share of ($1.39) for the second quarter of 2026.
• This GAAP loss is attributed to acquisition-related purchase accounting charges, including amortization of acquired intangibles and inventory step-up.

Risks

• Potential risks include failure to realize anticipated benefits from the BDS acquisition.
• Delays in integrating the BDS businesses could impact the realization of benefits.
• The ability to implement the business strategy and achieve revenue and cost synergies is a risk.
• Future financial and operational performance is subject to various risks and uncertainties.
• Economic and market conditions, strategic initiatives, and adapting to global dynamics pose risks.
• Supply chain challenges and the impact of tariffs are potential risks.
• The company's competitive positioning and technological capabilities are subject to change.
• Forward-looking statements are subject to risks detailed in SEC filings, including the Form 10-K.

Future Outlook

The company is raising its full-year 2026 guidance, expecting 7% to 9% organic constant currency revenue growth and adjusted EPS between $14.45 and $14.65. For the third quarter of 2026, organic constant currency revenue growth is projected at 8% to 10%, with adjusted EPS expected between $3.95 and $4.05.

Management Comments

• "Thanks to the hard work of our teams, we delivered industry-leading growth again this quarter, executing ahead of guidance across all four divisions."
• "Organic revenue grew 9% in constant currency, and our newly acquired businesses grew mid-single-digits in their first full quarter under Waters ownership."
• "This performance reflects strong execution across the combined Company as our integration continues to gain momentum, while the recovery across our end markets has broadened with previously lagging customer segments now returning to growth."
• "With momentum building across our portfolio, end markets, and synergies, we are raising every component of our full-year 2026 guidance."
• "Looking ahead, as end market conditions continue to strengthen and our growth strategy compounds, Waters is better positioned today than at any point in our recent history, with a broader portfolio, a larger installed base, and the clearest set of growth catalysts we have ever had."

Industry Context

StockSavvy.ai notes that Waters Corporation's strong performance, particularly in organic revenue growth and the successful integration of acquired businesses, aligns with a broader recovery and expansion in end markets within the life sciences and diagnostics sectors. The company's focus on analytical technologies and informatics positions it well to capitalize on these trends.

Stakeholder Impact

• Shareholders: Positive impact expected from raised full-year guidance and strong Q2 performance, potentially leading to increased stock value.
• Employees: Continued focus on integration and growth may create opportunities and require adaptation.
• Customers: Benefit from advanced analytical technologies and informatics aimed at improving drug development, food safety, and patient outcomes.
• Suppliers: Potential for increased demand for consumables and components due to higher revenue and growth.

Next Steps

• Continue integration of acquired Biosciences and Diagnostic Solutions businesses.
• Execute on the 180-day growth revitalization plan.
• Capitalize on the broadening recovery across end markets.
• Leverage a broader portfolio and larger installed base for future growth.
• Focus on delivering new analytical instruments, software, and consumables.

Key Dates

Recommendation

The company delivered better-than-expected results and raised guidance, which is positive. However, the GAAP loss due to acquisition accounting and the inherent risks associated with integration and future market conditions warrant a cautious 'hold' rating until sustained performance is demonstrated.

Keywords

Waters Corporation, financial results, revenue growth, adjusted EPS, organic revenue, life sciences, diagnostics, acquisition integration